Get the Stockscreener App
27.84
1.07%
-0.30
After Hours:
27.84
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $27.84, with a volume of 6.64M.
It is down -1.07% in the last 24 hours and down -22.34% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.
See More
Previous Close:
$28.14
Open:
$28.26
24h Volume:
6.64M
Relative Volume:
1.36
Market Cap:
$14.21B
Revenue:
$17.28B
Net Income/Loss:
$108.00M
P/E Ratio:
139.20
EPS:
0.2
Net Cash Flow:
$391.00M
1W Performance:
-3.30%
1M Performance:
-22.34%
6M Performance:
-23.81%
1Y Performance:
-33.90%
1-Day Range:
$26.78
$28.26
1-Week Range:
$26.25
$30.82
52-Week Range:
$26.25
$41.90
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(847) 948-2000
Address
ONE BAXTER PKWY, DEERFIELD, IL
Compare BAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
27.84 | 14.21B | 17.28B | 108.00M | 391.00M | 0.20 |
|
ISRG
Intuitive Surgical Inc
|
493.60 | 161.79B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
201.78 | 57.94B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
89.61 | 44.32B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
213.99 | 30.92B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
77.46 | 15.43B | 3.90B | 392.30M | 288.10M | 1.95 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Baxter International Enters Oversold Territory (BAX) - Nasdaq
Baxter International (NYSE:BAX) Reaches New 12-Month LowTime to Sell? - MarketBeat
Russell Investments Group Ltd. Has $50.90 Million Stock Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery - PharmiWeb.com
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL.com
Cullen Capital Management LLC Decreases Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Global Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat - GuruFocus
Breakthrough: Baxter's Enhanced Hemopatch Eliminates Surgery Prep Time with Room-Temperature Storage - Stock Titan
Baxter International Inc. (NYSE:BAX) Shares Bought by Geode Capital Management LLC - MarketBeat
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter International (NYSE:BAX) Sets New 12-Month LowTime to Sell? - MarketBeat
Wound Care Market to Witness Remarkable Growth with 3M, Baxter, - openPR.com
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Baxter International Inc.(BAX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Artificial Kidney Market to See Revolutionary Growth | Baxter - openPR.com
Baxter International Inc (BAX) Shares Down 3.27% on Apr 7 - GuruFocus
Citigroup Adjusts Baxter International Price Target to $35 From $37, Maintains Neutral Rating - MarketScreener
Baxter stock touches 52-week low at $28.22 amid market challenges - Investing.com Australia
Baxter stock touches 52-week low at $28.22 amid market challenges By Investing.com - Investing.com South Africa
Intravenous Solutions Market Is Booming Worldwide | Baxter - openPR.com
Allstate Corp Makes New $450,000 Investment in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International (NYSE:BAX) CEO Change as Stock Dips 2% Last Quarter - Yahoo Finance
Baxter International Inc. (NYSE:BAX) Short Interest Update - MarketBeat
Healthcare: Policy Uncertainty Is Countered by Interest in Defensive Stocks - Morningstar
US hospitals strained by IV fluid supply limits after Helene hit production site - AOL.com
Evercore ISI Adjusts Baxter International Price Target to $45 From $44, Maintains Outperform Rating - MarketScreener
Baxter International Inc. (NYSE:BAX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Baxter CEO pay surged before his departure — along with the median employee’s wage - Medical Design & Outsourcing
Is Baxter International Inc. (BAX) the Most Undervalued Healthcare Stock to Buy According to Analysts? - Insider Monkey
Baxter International (NYSE:BAX) investors are sitting on a loss of 55% if they invested five years ago - simplywall.st
Baxter International Sued Over Retirement Plan Investment Option - Bloomberg Law News
This Ultracheap Stock to Buy Is a Compelling Value Investment - Morningstar
174,176 Shares in Baxter International Inc. (NYSE:BAX) Purchased by KLP Kapitalforvaltning AS - MarketBeat
SHAREHOLDER ALERT: Potential Recovery for Baxter International Inc. (BAX) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Sound Shore Management Inc. CT Takes $72.45 Million Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
India Pharmacy Automation Market Competition, Forecast & - GlobeNewswire
India Pharmacy Automation Market Competition, Forecast & Opportunities Report 2025 Featuring Becton Dickinson, Omnicell, Baxter International, Cerner, and TouchPoint - GlobeNewswire
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):